Diabetes is a major health challenge that affects millions of people worldwide. Managing diabetes effectively requires monitoring blood glucose levels continuously, typically through invasive sensing devices such as continuous glucose monitors (CGMs)...
Continuous glucose monitoring (CGM) devices allow real-time glucose readings leading to improved glycemic control. However, glucose predictions in the lower (hypoglycemia) and higher (hyperglycemia) extremes, referred as glycemic excursions, remain c...
BACKGROUND: The use of large language models (LLMs) in healthcare has expanded significantly with advances in natural language processing. Models, such as ChatGPT and Google Gemini, are increasingly used to generate human-like responses to questions,...
Cerebral alterations are associated with diabetic peripheral neuropathy (DPN) and neuropathic pain, including reductions in brain volumes, cortical thickness, sulcus depth, and alterations in metabolites and functional connectivity. This study combin...
Personalized blood glucose (BG) prediction in Type 1 Diabetes (T1D) is challenged by significant inter-patient heterogeneity. To address this, we propose BiT-MAML, a hybrid model combining a Bidirectional LSTM-Transformer with Model-Agnostic Meta-Lea...
The co-occurrence of osteoporosis (OP) and type 1 diabetes mellitus (T1DM) represents a clinically significant comorbidity pattern, characterized by skeletal fragility and insulin deficiency. While epidemiological links exist, their shared molecular ...
Diabetic kidney disease (DKD) progression is not well understood. Using high-throughput proteomics, biostatistical, pathway and machine learning tools, we examine the urinary Complement proteome in two prospective cohorts with type 1 or 2 diabetes an...
BACKGROUND: There is uncertainty regarding the association between continuous glucose monitoring (CGM), derived glycemic metrics, and metabolic dysfunction-associated steatotic liver disease (MASLD) in individuals with type 1 diabetes (T1D).
Journal of diabetes science and technology
Jul 1, 2025
BACKGROUND: Since the discovery of the life-saving hormone insulin in 1921 by Dr Frederick Banting in 1921, there have been many critical discoveries and technical breakthroughs that have enabled people living with type 1 diabetes (T1D) to live longe...
Hypoglycemia is a major challenge for people with diabetes. Therefore, glycemic monitoring is an important aspect of diabetes management. However, current methods such as finger pricking and continuous glucose monitoring systems (CGMS) are invasive, ...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.